Measurement of thiopurine S-methyltransferase activity in human blood samples based on high-performance liquid chromatography: Reference values in erythrocytes from children

Annals of Clinical Biochemistry

Volumn 40, Issue 1, 2003, Pages 86-93

  Keizer Garritsen, Jenneke J ^a   Brouwer, Connie ^a   Lambooy, Lambert H J ^a   Ter Riet, Patricia ^a   Bökkerink, Jos P M ^a   Trijbels, Frans J M ^a   De Abreu, Ronney A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

6 METHYLTHIOINOSINE; MERCAPTOPURINE; METHYLTRANSFERASE; S ADENOSYLMETHIONINE;

ARTICLE; BIOASSAY; BLOOD; BLOOD SAMPLING; BONE MARROW; CALCULATION; CELL TYPE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LYMPHOBLAST; MALE; MEASUREMENT; MONONUCLEAR CELL; PRIORITY JOURNAL; SCREENING; SEX DIFFERENCE; STANDARD;

6-MERCAPTOPURINE; BONE MARROW; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERYTHROCYTES; HUMANS; KINETICS; LEUKOCYTES, MONONUCLEAR; METHYLTRANSFERASES; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 0037218412     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456303321016222     Document Type: Article

References (28)

1. Pinkel D. Intravenous mercaptopurine: Life begins at 40. J Clin Oncol 1993; 11: 1826-31
2. Kerstens PJSM, Stolk JN, Hilbrands LB, van der Putte LBA, De Abreu RA, Boerbooms AMT. 5′-Nucleotidase and azathioprine-related bone-marrow toxicity. Lancet 1993; 342: 1245-6
3. Dutz JP, Ho VC. Immunosuppressive agents in dermatology. An update. Dermatol Clin 1998; 16: 235-51
4. Holme SA, Duley JA, Sanderson J, Routledge PA, Anstey AV. Erythrocyte methyltransferase assessment prior to azathioprine use in the UK. QJM 2002; 95: 439-44
5. Kaklamani VG, Kaklamanis PG. Treatment of Behçet's disease: An update. Semin Arthritis Rheum 2001; 30: 299-312
6. Heesen C, Hauer S, Hadji-Abdobrahim B, Berenbeck C, Burmann C, Emskotter T. Current status of multiple sclerosis therapy in Germany: A national survey. Eur J Neurol 1999; 6: 35-8
7. Keuzenkamp-Jansen CW, van Baal JM, De Abreu RA, de Jong JGN, Zuiderent R, Trijbels JMF. Detection and identification of 6-methylmercapto-8-hydroxypurine: A major metabolite of 6-mercaptopurine in plasma during intravenous administration. Clin Chem 1996; 42: 380-6
8. Weinshilboum RM, Sladek SL. Mercaptopurine pharmacokinetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980; 32: 651-2
9. McLeod HL, Lin JS, Scott EP, Pui CH, Evans WE. Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 1994; 55: 15-20
10. Hon YY, Fessing MY, Pui CH, Relling MV, Krynetski EY, Evans WE. Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Genet 1999; 8: 371-6
11. Evans WE, Homer M, Chu YQ, Kalwinsky D, Roberts WM. Altered mercaptopurine metabolism, toxic effects, and dose requirement in a thiopurine-deficient child with acute lymphoblastic leukemia. J Pediatr 1991; 119: 985-9
12. Lennard L, Gibson BE, Nicole T, Lilleyman JS. Congenital thiopurine methyltransferase during treatment for acute lymphoblastic leukemia. Arch Dis Child 1993; 69: 570-9
13. Soria-Royer C, Legrendre C, Mircheva J, Premel S, Blaune P, Kreis H. Thiopurine methyltransferase activity to access azathioprine myelotoxicity in renal transplant recipients. Lancet 1993; 341: 1593-4
14. Kerstens PJSM, Stolk JN, De Abreu RA, Lambooy LHJ, van der Putte LBA, Boerbooms AMT. Azathioprine-related bone marrow toxicity and low activities of purine enzymes in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 142-5
15. Stolk JN, Boerbooms AMT, De Abreu RA, de Koning DGM, van Beusekom HJ, Hussink Muller W, et al. Reduced thiopurine methyltransferase activity and development of side effects of azathioprine in the treatment of rheumatoid arthritis. Arthritis Rheum 1998; 41: 1858-66
16. Lennard L, Lilleyman JS, Van Loon J, Weinshilboum RM. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia. Lancet 1990; 336: 225-9
17. Lennard L, Lilleyman JS. Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. J Clin Oncol 1989; 7: 1816-23
18. Lennard L, Van Loon JA, Lilleyman JS, Weinshilboum RM. Thiopurine pharmacogenetics in leukemia. Correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin Pharmacol Ther 1987; 41: 18-25
19. De Abreu RA, Peters G J, Bakkeren JAJM, Veerkamp JH. Discrepancies in ribonucleotide concentrations in human lymphocytes isolated from heparinized and defibrinized blood. Clin Chim Acta 1985; 145: 349-55
20. Stet EH, De Abreu RA, Janssen YPG, Bökkerink JPM, Trijbels JMF. A biochemical basis for synergism of 6-mercaptopurine and mycophenolic acid in Molt F4, a human malignant T-lymphoblastic cell line. Biochim Biophys Acta 1993; 1180: 277-82
21. Weinshilboum RM, Raymond FA, Pazmino PA. Human erythrocyte thiopurine methyltransferase: Radiochemical microassay and biochemical properties. Clin Chim Acta 1978; 85: 323-33
22. Relling MV, Hancock ML, Rivera GK, Sandlund JT, Ribeiro RC, Krynetski EY, et al. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst 1999; 91: 1983-5
23. Keuzenkamp-Jansen CW, Leegwater PAJ, De Abreu RA, Lambooy MAH, Bökkerink JPM, Trijbels JMF. Thiopurine methyltransferase: A review and a clinical pilot study. J Chromatogr B 1996; 678: 15-22
24. Klemetsdal B, Straume B, Lysaa R, Giverhaug T, Aarbakke J. Erythrocyte fraction affects red blood cell thiopurine methyltransferase activity. Eur J Clin Pharmacol 1995; 48: 495-9
25. Klemetsdal B, Wist E, Aarbakke J. Gender differences in red blood cell thiopurine methyltransferase activity. Scand J Clin Lab Invest 1993; 53: 747-9
26. SzumLanski CL, Honchel R, Scott MC, Weinshilbaum RM. Human liver thiopurine methyltransferase pharmacogenetics: Biochemical properties, liver-erythrocyte correlation and presence of isozymes. Pharmacogenetics 1992; 2: 148-59
27. Lee EJ, Kalow W. Thiopurine S-methyltransferase activity in a Chinese population. Clin Pharmacol Ther 1993; 54: 28-33
28. Jacqz-Aigrain E, Bessa E, Medard Y, Mircheva Y, Vilmer E. Thiopurine methyltransferase activity in a French population: HPLC assay conditions and effects of drugs and inhibitors. Br J Clin Pharmacol 1994; 38: 1-8